BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 8471334)

  • 1. Cervical cancer incidence and mortality trends in Finland and Estonia: a screened vs. an unscreened population.
    Aareleid T; Pukkala E; Thomson H; Hakama M
    Eur J Cancer; 1993; 29A(5):745-9. PubMed ID: 8471334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mass screening programmes and trends in cervical cancer in Finland and the Netherlands.
    van der Aa MA; Pukkala E; Coebergh JW; Anttila A; Siesling S
    Int J Cancer; 2008 Apr; 122(8):1854-8. PubMed ID: 18067129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of organised screening on cervical cancer incidence and mortality in Finland, 1963-1995: recent increase in cervical cancer incidence.
    Anttila A; Pukkala E; Söderman B; Kallio M; Nieminen P; Hakama M
    Int J Cancer; 1999 Sep; 83(1):59-65. PubMed ID: 10449609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a mass screening program on the risk of cervical cancer.
    Louhivuori K
    Cancer Detect Prev; 1991; 15(6):471-5. PubMed ID: 1782637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in cervical cancer incidence and survival in Estonia from 1995 to 2014.
    Ojamaa K; Innos K; Baburin A; Everaus H; Veerus P
    BMC Cancer; 2018 Nov; 18(1):1075. PubMed ID: 30404606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cervical cancer screening programme in Finland with an example on implementing alternative screening methods.
    Anttila A; Nieminen P
    Coll Antropol; 2007 Apr; 31 Suppl 2():17-22. PubMed ID: 17600933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of implementing a nationwide cervical cancer screening program on female population coverage by Pap-tests in Estonia.
    Veerus P; Arbyn M; Amati C; Paolo B;
    Tumori; 2010; 96(4):524-8. PubMed ID: 20968130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of mass screening on incidence and mortality of squamous and adenocarcinoma of cervix uteri.
    Nieminen P; Kallio M; Hakama M
    Obstet Gynecol; 1995 Jun; 85(6):1017-21. PubMed ID: 7770247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of population screening for carcinoma of the uterine cervix in Finland.
    Hakama M
    Maturitas; 1985 May; 7(1):3-10. PubMed ID: 4021826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cervical cancer screening programme in Finland.
    Anttila A; Nieminen P
    Eur J Cancer; 2000 Nov; 36(17):2209-14. PubMed ID: 11072206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in mortality from cervical cancer in the Nordic countries: association with organised screening programmes.
    Lăără E; Day NE; Hakama M
    Lancet; 1987 May; 1(8544):1247-9. PubMed ID: 2884378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mass screenings for cervical cancer in Finland 1963-71. Organization, extent, and epidemiological implications.
    Hakama M; Joutsenlahti U; Virtanen A; Räsänen-Virtanen U
    Ann Clin Res; 1975 Apr; 7(2):101-11. PubMed ID: 1181974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in cervical cancer incidence and mortality in Bulgaria, Estonia, Latvia, Lithuania and Romania.
    Arbyn M; Antoine J; Valerianova Z; Mägi M; Stengrevics A; Smailyte G; Suteu O; Micheli A
    Tumori; 2010; 96(4):517-23. PubMed ID: 20968129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A screening programme for cervical cancer that worked.
    Hakama M; Louhivuori K
    Cancer Surv; 1988; 7(3):403-16. PubMed ID: 3242792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of cervical cancer screening in Scandinavia.
    Day NE
    Obstet Gynecol; 1984 May; 63(5):714-8. PubMed ID: 6717876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of cervical cancer after a negative Pap smear.
    Viikki M; Pukkala E; Hakama M
    J Med Screen; 1999; 6(2):103-7. PubMed ID: 10444730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Divergent trends in lung cancer incidence by gender, age and histological type in Estonia: a nationwide population-based study.
    Aareleid T; Zimmermann ML; Baburin A; Innos K
    BMC Cancer; 2017 Aug; 17(1):596. PubMed ID: 28854969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cervical cancer. Mass screening, incidence and mortality in Finland.
    Timonen S; Pyörälä T
    Acta Obstet Gynecol Scand Suppl; 1977; 67():13-9. PubMed ID: 269640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-related incidence of cervical cancer supports two aetiological components: a population-based register study.
    Seppä K; Pitkäniemi J; Malila N; Hakama M
    BJOG; 2016 Apr; 123(5):772-8. PubMed ID: 26599730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cervical cancer incidence in elderly women-biology or screening history?
    Lynge E; Lönnberg S; Törnberg S
    Eur J Cancer; 2017 Mar; 74():82-88. PubMed ID: 28335890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.